The HIT-TRAP Trial

• Status: Unknown status
• Trial end date: 2005-11-01

Summary

Randomised, double blind trial in non-intensive care trauma patients comparing unfractionated heparin (UFH) or low-molecular-weight heparin (LMWH) in heparin-induced thrombocytopenia (HIT).

• Phase: Phase 4

Details

• Lead Sponsor: University Medicine Greifswald
• Collaborator: Novartis
• Treatments: Calcium heparin; Certoparin; Dalteparin; Heparin; Heparin, Low-Molecular-Weight